













Homepage - Cardiol Therapeutics
























































Menu
Close



About Us

Company Overview
Our History
Leadership
Board of Directors
Our Advisors


Therapeutic Areas

COVID-19 and CVD
Acute Myocarditis
Heart Failure


Research

R&D Partners
Our Science
Resources


Pipeline
CardiolRX™
Investors

Events & Presentations
Press Releases
Analyst Coverage
Stock Information
Filings & Financials
Corporate Governance
Contact Us


 








Dedicated to Conquering Heart Failure


 A clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease







COVID-19 and CVD
Cardiol has been approved by the FDA for a Phase II/III clinical trial to test the efficacy of CardiolRx™ in improving outcomes for COVID-19 patients with cardiovascular disease (CVD).


						Learn More
				





Acute Myocarditis
Cardiol is planning a Phase II international trial of acute myocarditis, the most common cause of sudden cardiac death in people under 35 years of age.


						Learn More
				

 



Heart Failure
Committed to conquering a serious condition that affects more than 26 million people globally.


						Learn More
				




LATEST NEWS


					All News
				





Press Release
Cardiol Therapeutics Closes $22 Million Bought Deal Offering
May 12, 2021



May 12, 2021
Cardiol Therapeutics Closes $22 Million Bought Deal Offering





Press Release
Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering
May 06, 2021



May 06, 2021
Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering





Press Release
Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering
May 05, 2021



May 05, 2021
Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering















About Us
Therapeutic Areas
Research
Pipeline
CardiolRX™
Investors
Contact
 

TSX:CRDL OTCQX:CRTPF FSE:CT9









Sign up to receive the latest news from Cardiol Therapeutics



Leave this field empty if you're human:  


© 2021 Cardiol Therapeutics Inc. All rights reserved.      Terms of Use      Privacy Policy




































